 |
 |
ÃÖ¼Ò 10ÀÏÀÌ ¼Ò¿äµÇ´Â Karyotype Analysis¿¡ ºñÇØ MetaphaseÁغñ ¾øÀÌ 3Àϳ» ºÐ¼® °¡´É |
 |
Sample DNA¸¸À¸·Î ºÐ¼® °¡´É (Paraffin Block, Fixed Tissue) |
 |
»ó¿ë BAC aCGH Áß ÃÖ´Ù probe °³¼ö |
 |
¸ðµç probe cloneÀ» FISH·Î Àç°ËÁõÇÏ¿© ½Å·ÚÇÒ ¼ö ÀÖÀ½ |
 |
¶Ù¾î³ ÀçÇö¼º°ú Ź¿ùÇÑ Signal-to-Noise ºñÀ² |
 |
¸¶Å©·ÎÁ¨¿¡¼ ÀÚü ±¸ÃàÇÑ Korean Genome MapÀ¸·Î Á¦ÀÛÇÏ¿´À¸¹Ç·Î ·Î¿Æ¼°¡ ¾øÀ½ |
 |
ISO9001 ¹× ISO13485 ǰÁú °ü¸® ±âÁØ¿¡ ÀÇÇÑ »ý»êÀ¸·Î ¹ÏÀ» ¼ö Àִ ǰÁú |
|
 |
|
 |
| |
 |
|
 |
¸¶Å©·ÎÁ¨Àº 2001³â Çѱ¹ÀÎ °Ô³ð Áöµµ BAC Clone Library ±¸ÃàÇÏ¿´½À´Ï´Ù. ÃÑ 10¸¸¿© °³ÀÇ BAC clone |
| |
À» ¸¸µé¾úÀ¸¸ç, ¸ðµç BAC cloneµéÀÇ insertion part¸¦ end-sequencing ÇÏ¿´½À´Ï´Ù. ±× ÈÄ bioinformatics |
| |
toolÀ» ÀÌ¿ë, 10¸¸ °³ÀÇ BAC cloneÀÇ ¼ø¼¿Í À§Ä¡¸¦ È®Á¤ÇÏ¿© ÃÖÁ¾ÀûÀ¸·Î library¸¦ ¿Ï¼ºÇÏ¿´½À´Ï´Ù. |
| |
|
 |
|
 |
Çѱ¹ÀÎ °Ô³ð library¸¦ ¹ÙÅÁÀ¸·Î ¸¶Å©·ÎÁ¨Àº array CGH chipÀ» Á¦ÀÛÇÏ¿´½À´Ï´Ù. À̸¦ À§Çؼ 10¸¸ °³ |
| |
ÀÇ BAC clone Áß¿¡¼ 4,500¿© °³ÀÇ BAC cloneÀ» ¼±Á¤ÇÏ¿´½À´Ï´Ù. Genome variationÀÌ ºó¹øÈ÷ º¸°í |
| |
µÈ ºÎºÐÀ» À§ÁÖ·Î ÇÏ°í °¢ probe »çÀÌÀÇ °£°ÝÀ» °í·ÁÇÏ¿© 1Â÷·Î probe È帱ºÀ» Á¤ÇÑ ´ÙÀ½, ¸ðµç ÈÄ |
| |
º¸ CloneµéÀ» FISH(Fluorescence In Situ Hybridization) probe½ÇÇèÀ¸·Î ½ÇÁ¦ °ËÁõÇÏ¿´½À´Ï´Ù. |
| |
 |
|
|
 |
|
 |
Microarray ºÐ¼®°á°ú À¯È¿ÇÑ º¯È°¡ ÀÖ´Â °ÍÀ¸·Î ÆÇ´ÜµÈ °¢ cloneÀÇ FISH¸¦ ÅëÇÏ¿© |
| | SampleÀÇ metaphase ȤÀº interphase¿¡¼ ÀçÈ®ÀÎÀÌ °¡´ÉÇÕ´Ï´Ù. |
| | ¶ÇÇÑ À̿ܿ¡ ±âŸ ÁÖ¹® Á¦ÀÛ ¼ºñ½ºµµ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº º°µµ¹®ÀÇ ¹Ù¶ø´Ï´Ù |
|
 |
|
|
 |
|
 |
| ½ÇÇè ¹æ¹ýÀº À§¿Í °°½À´Ï´Ù. ¼·Î ´Ù¸¥ »öÀÇ dye·Î stainingµÈ test sample°ú reference sampleÀ» °¢°¢ °°Àº ¾çÀ¸·Î hybridization½Ãŵ´Ï´Ù.(Competitive hybridization) ´ëºÎºÐÀÇ chromosomeÀº test¿Í reference sample¿¡¼ °°Àº copy number¸¦ °®±â ¶§¹®¿¡ log ratio plot¿¡¼ 0¿¡ À§Ä¡ÇÕ´Ï´Ù. ¹Ý¸é test sample¿¡¼ copy number(ex: duplication)°¡ Áõ°¡Ç߰ųª °¨¼Ò(ex: deletion)Çß´Ù¸é ±×¸²¿¡¼¿Í °°ÀÌ ´Ù¸¥ ¼öÄ¡¸¦ º¸¿©ÁÝ´Ï´Ù. |
| |
 |
|
 |
 |
Array comparative genomic hybridization analysis of uterine leiomyosarcoma.
Gynecologic Oncology. 2005 Dec;99(3):545-51. Epub 2005 Aug 24. |
 | Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer. 2006 Apr 12;6:92
|
 |
The genetic differences between gallbladder and bile duct cancer cell lines. Oncology Reports. 2006(16):949-56
|
 | Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines. Cancer Genetics and Cytogenetics. 2006 Apr 1; 166(1):56-64ii
|
|
 |
|
| |